Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Steakholder Foods Ltd.
SIC 2000 · Food & Kindred Products
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Steakholder Foods Ltd.
SIC 2000 · Food & Kindred Products
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Steakholder Foods Ltd.
SIC 2000 · Food & Kindred Products
Notes
Support
about
terms
$
MTTCF
Steakholder Foods Ltd.
CIK:
0001828098
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]
Revenue
$ 10
Cost of revenue
22
Gross loss
(12)
Research and development, net
2,189
3,518
7,095
Marketing
774
1,192
1,937
Marketing with related party
172
745
General and administrative
4,040
3,582
4,401
Other expense, net
413
Total operating loss
7,416
8,476
14,178
Financial expenses, net
145
45
1,369
Loss from continuing operations
7,561
8,521
15,547
Net loss from discontinued operations
3,686
1,317
Loss for the year
11,247
8,521
16,864
Other comprehensive income:
Foreign currency translation differences
(230)
Other comprehensive income for the year, net
(230)
Total comprehensive loss
$ 11,247
$ 8,521
$ 16,634
Net loss per share from continuing operations – basic (in Dollars per share)
$ (0.005)
$ (0.02)
$ (0.07)
Net loss per share from continuing operations – diluted (in Dollars per share)
(0.005)
(0.02)
(0.07)
Net loss per share from discontinued operations – basic (in Dollars per share)
(0.002)
(0.01)
Net loss per share from discontinued operations – diluted (in Dollars per share)
$ (0.002)
$ (0.01)
Weighted average shares outstanding – basic (in Shares)
1,488,257,310
417,642,811
236,645,676
Weighted average shares outstanding – diluted (in Shares)
1,488,257,310
417,642,811
236,645,676
v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:
Net Loss
$ (11,247)
$ (8,521)
$ (16,864)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
770
467
503
Change in fair value of financial liabilities
(4)
Change in fair value of other investment
1,148
Change in fair value of marketable securities
20
179
84
Change in lease right of use assets
2,818
424
417
Change in inventory
59
Change in lease liabilities
(2,812)
(356)
(524)
Share-based compensation
589
205
1,114
Share-based compensation with related party
172
745
Loss from lease remeasurement
302
Loss from the sale of fixed assets
287
23
Loss of control of discontinued operation
2,856
(178)
Decrease (increase) in prepaid expenses and other current assets
130
(30)
153
Interest expense, net
26
Foreign exchange gain or losses
91
(71)
162
Non-cash finance expenses
160
Decrease in trade payables
(108)
(41)
(460)
Increase (decrease) in accounts payables and accruals
(686)
(909)
977
Net cash used in operating activities
(6,745)
(8,458)
(12,727)
Cash flows from investing activities:
Acquisition of fixed assets
(113)
(985)
(270)
Increase (decrease) in restricted deposit
179
(14)
16
Investment in convertible loan
(1,740)
(54)
Proceeds from other investment
88
Acquisition of other investments, net of cash acquired
181
Proceeds from the sale of (Investment in) marketable securities
68
65
(435)
Proceeds from the sale of fixed assets
349
32
Net cash decrease from loss of control over discontinued operations
(198)
(163)
Net cash used in investing activities
(1,274)
(956)
(764)
Cash flows from financing activities:
Proceeds from issuance of shares and warrants
8,265
422
12,500
Proceeds from convertible loans
870
Issuance costs
(842)
(642)
(1,243)
Proceeds from exercise of warrants and stock options
1,499
6,604
Net cash provided by financing activities
9,792
6,384
11,257
Effect of exchange rate changes on cash and cash equivalents
54
42
198
Increase (decrease) in cash and cash equivalents
1,827
(2,988)
(2,036)
Cash and cash equivalents, beginning of the year
1,260
4,248
6,284
Cash and cash equivalents end of the year
3,087
1,260
4,248
Supplemental information for non-cash transactions
Non-cash purchase of property and equipment
52
Issuance costs
75
Acquisition of a subsidiary
965
Convertible loan conversion
1,793
Conversion of convertible loan to shares
$ 897
v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
CURRENT ASSETS:
Cash and cash equivalents
$ 3,087
$ 1,260
Marketable securities
14
102
Restricted deposits
201
Prepaid expenses and other current assets
388
411
Total current assets
3,690
1,773
NON-CURRENT ASSETS:
Restricted deposits
27
314
Long-term loan
54
Long term receivables
10
Right-of-use asset
2,788
Property and equipment, net
1,566
2,858
Total non-current assets
1,603
6,014
Total assets
5,293
7,787
CURRENT LIABILITIES:
Accounts payables and accruals
778
927
Other liabilities
77
192
Trade payables
39
166
Current lease liability
386
Total current liabilities
894
1,671
NON-CURRENT LIABILITIES
Long term lease liability
2,069
Total non-current liabilities
2,069
COMMITMENTS AND CONTINGENT LIABILITIES (Note 12)
SHAREHOLDERS’ EQUITY
Ordinary shares – no par value, Authorized 50,000,000,000 shares. Issued and outstanding 5,438,836,659 and 349,603,759 at December 31, 2025 and December 31, 2024, respectively
Additional paid in capital
94,343
82,744
Accumulated deficit
(89,944)
(78,697)
Total shareholders’ equity
4,399
4,047
Total liabilities and shareholders’ equity
$ 5,293
$ 7,787